These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7675950)

  • 1. Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.
    Carroll CB; Holloway V; Brotchie JM; Mitchell IJ
    Psychopharmacology (Berl); 1995 May; 119(1):55-65. PubMed ID: 7675950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
    Nash JE; Brotchie JM
    Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
    Hutson PH; Bristow LJ; Thorn L; Tricklebank MD
    Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices.
    Crawford M; Roberts PJ
    Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.
    Nash JE; Brotchie JM
    J Neurosci; 2000 Oct; 20(20):7782-9. PubMed ID: 11027242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site.
    Foster AC; Kemp JA
    J Neurosci; 1989 Jun; 9(6):2191-6. PubMed ID: 2542488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action.
    Mitchell IJ; Carroll CB
    Neurosci Biobehav Rev; 1997 Jul; 21(4):469-75. PubMed ID: 9195604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
    Mugnaini M; Meoni P; Bunnemann B; Corsi M; Bowery NG
    Br J Pharmacol; 2001 Apr; 132(8):1883-97. PubMed ID: 11309261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
    Kemp JA; Priestley T
    Mol Pharmacol; 1991 May; 39(5):666-70. PubMed ID: 1674587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
    Bennett S; Gronier B
    Eur J Pharmacol; 2005 Dec; 527(1-3):52-9. PubMed ID: 16307739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens.
    Kretschmer BD; Schmidt WJ
    J Neurosci; 1996 Feb; 16(4):1561-9. PubMed ID: 8778305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons.
    Benveniste M; Mienville JM; Sernagor E; Mayer ML
    J Neurophysiol; 1990 Jun; 63(6):1373-84. PubMed ID: 1972740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
    Karcz-Kubicha M; Wedzony K; Zajaczkowski W; Danysz W
    J Neural Transm (Vienna); 1999; 106(11-12):1189-204. PubMed ID: 10651113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ
    J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.